Gelonghui, May 8 | Novo Zhiyuan (688315.SH) said on an interactive platform that the company focuses on pioneering the application of cutting-edge molecular biology technology and high-performance computing in life science research and human health, and is committed to becoming the world's leading provider of gene technology products and services. Currently, the business covers basic life science research services, medical research and technical services, and database sequencing platform services, providing services such as gene sequencing, mass spectrometry analysis, and bioinformation technology support for global research universities, research institutes, hospitals, pharmaceutical R&D enterprises, agricultural enterprises, etc.